SCHIMMELPENNINK EVERT B. (President, CEO and Secretary) purchased 57.1% of their position (28.09K shares) of LENZ THERAPEUTICS, INC. on the open market
Open‑market purchase worth $251.4K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 3/30/2026ACC: 0001713795-26-000004
DirectorOfficer· President, CEO and Secretary
Since Mar 2024
+28.09K
Net shares
Net buyer
$251.4K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
28.09K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+28.09K
Price / share
$8.95
Trade value
$251.41K
% of position
57.1%
3/27/2026
49.20K→77.29K
Total
Net shares
+28.09K
Net value
$251.41K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/27/2026 | P · Purchase | +28.09K | $8.95 | $251.41K | 57.1% | 49.20K | 77.29K |
| Total | +28.09K | $251.41K | ||||||
Derivative Transactions0
No derivative transactions reported